Literature DB >> 16497529

Hyperammonemia increases sensitivity to LPS.

Juan C Marini1, Suzanne R Broussard.   

Abstract

Metabolic and cognitive alterations occur during hyperammonemia. Here, we report that chronic hyperammonemia also leads to increased sensitivity to LPS. Sparse-fur mice were challenged i.p. with LPS or saline control and then tested for motivation to investigate a novel juvenile over 24 h. Cytokine, ammonia, and urea concentration were quantified at the peak of sickness (2 h post injection). Chronic hyperammonemic Otc(spf-ash) mice displayed more pronounced and prolonged sickness behavior in response to LPS (P=0.02). LPS significantly (P<0.0001) increased plasma concentrations of TNFalpha, IL-1 beta, IL-6, IL-15, IL-9, IL-2, IL-1 alpha, IL-1 beta, Rantes, MIP1 alpha, MIP1 beta, MCP-1, KC, GM-CSF, G-CSF, Eotaxin, IL-13, and IL-12 in both wild type and Otc(spf-ash) mice. No significant genotype/treatment interactions (P>0.1) were detected for any cytokine. Adult Otc(spf-ash) mice (168+/-41 microM) had four times higher plasma ammonia compared to wild type mice (40 +/- 6 microM) (P=0.002). Two hours after LPS injection, plasma ammonia concentrations tended (P=0.08) to decrease in both wild type and Otc(spf-ash) mice. Learning and memory behaviors were assessed in mice under basal conditions to determine the impact of chronic hyperammonemia on cognition. Otc(spf-ash) mice performed significantly poorer in the two trial Y-maze (P=0.02) and the Morris water maze (P=0.001) than their littermate wild type controls. Taken together, these data indicate that chronic hyperammonemia results in impaired cognition and creates a state of LPS hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497529     DOI: 10.1016/j.ymgme.2005.12.013

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  13 in total

1.  Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy.

Authors:  Vicente Felipo; Amparo Urios; Encarna Montesinos; Inmaculada Molina; Maria L Garcia-Torres; Miguel Civera; Juan A Del Olmo; Joaquin Ortega; Jose Martinez-Valls; Miguel A Serra; Norberto Cassinello; Abdallah Wassel; Esperanza Jordá; Carmina Montoliu
Journal:  Metab Brain Dis       Date:  2011-11-10       Impact factor: 3.584

Review 2.  Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

Authors:  Amit S Seyan; Robin D Hughes; Debbie L Shawcross
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

Review 3.  Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.

Authors:  Ming Luo; Jian-Yang Guo; Wu-Kui Cao
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 4.  Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation.

Authors:  Dominic R Aldridge; Edward J Tranah; Debbie L Shawcross
Journal:  J Clin Exp Hepatol       Date:  2014-06-30

Review 5.  Systemic inflammation and ammonia in hepatic encephalopathy.

Authors:  Thomas H Tranah; Godhev K Manakkat Vijay; Jennifer M Ryan; Debbie L Shawcross
Journal:  Metab Brain Dis       Date:  2012-12-07       Impact factor: 3.584

Review 6.  Hepatic encephalopathy: effects of liver failure on brain function.

Authors:  Vicente Felipo
Journal:  Nat Rev Neurosci       Date:  2013-10-23       Impact factor: 34.870

7.  Infectious precipitants of acute hyperammonemia are associated with indicators of increased morbidity in patients with urea cycle disorders.

Authors:  Peter J McGuire; Hye-Seung Lee; Marshall L Summar
Journal:  J Pediatr       Date:  2013-09-29       Impact factor: 4.406

8.  Potential role of Plasmodium falciparum-derived ammonia in the pathogenesis of cerebral malaria.

Authors:  Sammy Kimoloi; Khalid Rashid
Journal:  Front Neurosci       Date:  2015-07-03       Impact factor: 4.677

Review 9.  Hepatic encephalopathy: current challenges and future prospects.

Authors:  Mirashini Swaminathan; Mark Alexander Ellul; Timothy Js Cross
Journal:  Hepat Med       Date:  2018-03-22

Review 10.  Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease.

Authors:  Annarein J C Kerbert; Rajiv Jalan
Journal:  F1000Res       Date:  2020-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.